919.246.9846

[email protected]

Biologics & Advanced Therapies

Innovate Boldly. Transfer Seamlessly. Commercialize Reliably.

From monoclonal antibodies to gene and cell therapies, Kymanox® delivers the technical, regulatory, and manufacturing expertise needed to bring breakthrough biologics to patients. With 50+ biologics and advanced therapy programs supported and involvement in 100+ regulatory submissions, we help innovators accelerate development, ensure compliance, and achieve CGMP-ready commercialization.

Jump to Section

CMC/Pharma Science
Process Engineering
Regulatory Affairs
Supply Chain & Logistics
Digital Solutions

Chemistry, Manufacturing, and Controls (CMC)/Pharma Science

Advance complex biologics and advanced therapies with scalable, CGMP-aligned CMC solutions. Kymanox integrates upstream and downstream process development, formulation, and analytical rigor to ensure your program meets regulatory expectations and is ready for clinical and commercial success.

  • Formulation Development

    Develop scalable formulations and stability strategies tailored to biologics and advanced modalities, ensuring long-term product integrity.

  • Analytical Method Development

    Design, validate, and transfer robust analytical methods that support regulatory submissions and lifecycle management.

  • Drug–Device Compatibility

    Assess and optimize drug–device interactions for prefilled syringes, autoinjectors, and other delivery systems to ensure safety and efficacy.

  • Process Development

    Support end-to-end upstream and downstream process design aligned with CGMP principles to support clinical and commercial readiness.

  • Comparability Studies

    Establish biosimilar comparability and manage regulatory documentation to accelerate global approvals.

  • CDMO/CMO Vendor Oversight

    Guide vendor selection, onboarding, and management to ensure compliant and efficient technology transfer and manufacturing scale-up.

Brochure

Technology Transfer & Process Engineering

Move seamlessly from development to commercial manufacturing with proven expertise in process engineering, validation, and facility readiness. Kymanox ensures your biologics and advanced therapies scale compliantly, transfer smoothly, and launch successfully.

  • Technology transfer & scale-up execution 
  • Process validation & Continued Process Verification (CPV) 
  • Process Performance Qualification (PPQ) strategy, management, and documentation 
  • Combination product integration 
  • Facility and site readiness planning  

At Kymanox, we help you overcome resource limitations and close technology transfer gaps. We bring deep expertise in Quality by Design and industry best practices to ensure your projects stay on track, accelerate product launches, and avoid costly delays or rework.

Brochure

Regulatory Affairs & Quality Assurance

Streamline approvals and maintain long-term compliance with expert regulatory and quality guidance for biologics and advanced therapies. Kymanox integrates regulatory strategy, submission support, and quality systems to ensure your therapies meet evolving global standards while minimizing risk.

REGULATORY STRATEGY & SUBMISSIONS

IND/BLA planning, submission authoring, and engagement with global agencies.

ATMP & ACCELERATED PATHWAYS

Specialized support for gene/cell therapies and fast-track approval strategies.

INPECTION READINESS

BLA/PLI/PAI preparation, gap assessments, and mock audits.

QUALITY SYSTEMS & DIGITAL QMS

Implementation, remediation, and integration of scalable, inspection-ready quality frameworks.

WHY THIS MATTERS

Partnering with Kymanox gives you access to deep regulatory expertise combined with practical, proactive support designed to streamline regulatory activities, reduce compliance risk, and accelerate your time to market. We tailor solutions for both global and local regulatory requirements, helping you navigate complexity with confidence and agility.

Brochure

Supply Chain & Logistics

Ensure reliable, compliant, and uninterrupted supply of complex biologics and advanced therapies. Kymanox provides oversight from vendor selection to clinical trial, helping you manage risk and maintain regulatory confidence across the supply chain.

PARTNER MANAGEMENT

CDMO/CRO strategy, selection, and qualification with ongoing vendor oversight.

RISK & COMPLIANCE

Comprehensive risk assessment, contingency planning, and global CGMP audit support services.

COLD CHAIN & SPECIALTY LOGISTICS

Secure temperature-sensitive and specialty product transport to maintain integrity from site to patient.

Brochure

Digital Solutions

Modernize biologics development and manufacturing with secure, compliant digital systems. Kymanox helps you unlock real-time insights, streamline compliance, and enable Biopharma 4.0 practices across the product lifecycle.

  • Data Platforms & Automation
  • Advanced Analytics & AI/ML
  • PAT & Process Control
  • Digital Supply Chain
  • Data Integrity & Compliance
  • Secure, centralized data platforms
  • Automated batch records, Electronic Lab Notebooks (ELNs), and QMS
  • Predictive modeling and risk mitigation with Artificial Intelligence/Machine Learning (AI/ML)
  • Process optimization powered by real-time data
  • Digital integration of Process Analytical Technology (PAT) systems
  • Enhanced monitoring and manufacturing reliability
  • Connected vendor networks
  • Transparent, compliant logistics oversight
  • Digital integration of PAT regulatory-compliant data governance
  • Audit readiness through digital traceability

Sterilization Engineering

Our sterilization engineering team has developed portable, flexible solutions that deliver real-time data monitoring without sacrificing reliability. From complex formulations to challenging packaging requirements, our technology adapts to your specific needs.

Sterilization Validation

Kymanox sterilization and validation experts assist clients with cleaning, disinfection, and sterilization validations, sterility assurance, Sterile Barrier System (SBS) and Container Closure Integrity (CCI) testing, residuals testing, and bioburden reduction.

Development and Optimization of Sterilization Processes

We design and optimize sterilization process for all FDA established Category A methods (e.g., dry heat, ethylene oxide, steam, irradiation) as well as several FDA established Category B methods as well as novel sterilization methods.

Sterilization Strategy

Kymanox can conduct sterilization processes analyses including virtual dose mapping and dose visualization for complex complex irradiation programs. Additional dose uniformity calculations for all radiation sterilization processes, gas diffusion and heat transfer analyses, optimized exposure determinations for bioburden methodologies, and most resistant site determination.

Complete Sterilization Lifecycle

Sterilization Engineering provides design inputs early in the device design cycle for a successful development program with no surprises.

Brochure

Stay Connected with our Thought Leadership

  • Thought Leadership
  • Events
  • Podcasts
  • Case Studies

Industry Thought Leadership

Get expert insights, regulatory updates, and real-world lessons from the front lines of life science development—delivered monthly to your inbox.

Join the 10,000+ innovators who never miss a Kymanox update.

Subscribe

Kymanox in the Community

Our team travels to leading industry events to stay up to date and connected.

Events

Explore our Expertise

Subscribe to get a first listen to our podcast. Our podcast brings industry experts to discuss your favorite topics.

Explore Our Podcast

Success Stories

Our team has supported over 4,000 projects in the last year, and we want to share their stories with you.

Case Studies

Put our experts to work for you

Get in Touch